Lite Strategy

Lite Strategy Inc is a publicly traded company headquartered in San Diego, California, trading on NASDAQ under the ticker symbol LITS. Formerly known as MEI Pharma Inc, the company rebranded to Lite Strategy Inc in September 2025, reflecting its strategic transformation into the world's largest Litecoin Treasury Company and the first United States... publicly traded company to adopt Litecoin as its primary reserve asset. The company's core business model focuses on pioneering institutional-grade digital asset treasury strategies, accumulating and managing Litecoin holdings through active treasury management with the goal of concentrating LTC holdings per share as the ultimate metric of shareholder value. In August 2025, Lite Strategy acquired 929,548 Litecoin tokens for approximately 100 million dollars, establishing itself as a leader in corporate cryptocurrency treasury strategies. The company operates in partnership with GSR, a global leader in digital asset capital markets, which serves as both strategic advisor and digital asset treasury manager, providing liquidity, risk management, and strategic insight to support Litecoin adoption as a core treasury asset. Litecoin creator Charlie Lee serves as a board member, bringing expertise and credibility to the company's digital asset strategy. In addition to its digital asset treasury operations, Lite Strategy maintains a clinical-stage pharmaceutical portfolio that includes voruciclib, an oral cyclin-dependent kinase 9 inhibitor, and zandelisib, an oral selective PI3K inhibitor, both being developed as novel cancer therapies intended to improve outcomes for patients. The company's approach to oncology drug development involves evaluating drug candidates in combination with standard-of-care therapies to overcome known resistance mechanisms and address clear medical needs. Lite Strategy is led by Acting CEO and CFO Jay File and positions itself as providing investors the only United States publicly traded vehicle to gain institutional exposure to Litecoin for ...Read More